Evidence map›Paper›PMID 29786066›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2.

Sabrina Francesca Lisboa, Anzela Niraula, Leonardo Barbosa Resstel, Francisco Silveira Guimaraes, Jonathan P Godbout, John F Sheridan

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Sex-specific role of microglia in ΔNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. IL-1 Receptor-1 onBrain, behavior, & immunity - health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sabrina Francesca LisboaDepartment of Pharmacology, University of Sao Paulo (USP), Ribeirão Preto, São Paulo, 14049900, Brazil. sa_lisboa@hotmail.com.ORCID http://orcid.org/0000-0002-2069-3524
Anzela NiraulaDivision of Biosciences, Ohio State University, Columbus, OH, 43210, USA.
Leonardo Barbosa ResstelDepartment of Pharmacology, University of Sao Paulo (USP), Ribeirão Preto, São Paulo, 14049900, Brazil.
Francisco Silveira GuimaraesDepartment of Pharmacology, University of Sao Paulo (USP), Ribeirão Preto, São Paulo, 14049900, Brazil.
Jonathan P GodboutDivision of Biosciences, Ohio State University, Columbus, OH, 43210, USA.
John F SheridanDivision of Biosciences, Ohio State University, Columbus, OH, 43210, USA.ORCID http://orcid.org/0000-0002-6927-0266

Funding

Social threat primes myeloid progenitor cells and microglia: role in anxietyR01MH093473 · NIMH · OHIO STATE UNIVERSITY · PI SHERIDAN, JOHN F · 2012 to 2016
$1.9M
NIH HHS R01-MH-093472NIMH NIH HHS R01 MH093473
6 · The paper itself

Abstract

Psychosocial stress contributes to the development of psychiatric disorders. Repeated social defeat (RSD) is a murine stressor that causes a release of inflammatory monocytes into circulation. Moreover, RSD-induced anxiety-like behavior is dependent on the recruitment of these monocytes to the brain. Activation of the endocannabinoid (ECB) system may modulate both neuroendocrine and inflammatory responses mediated by stress. Therefore, we hypothesized that a cannabinoid receptor agonist would attenuate RSD-induced inflammation, anxiety, and stress sensitization. To test this hypothesis, mice received an injection of the synthetic cannabinoid

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalAnxiety DisordersBenzoxazinesBrainCannabinoid Receptor AgonistsDisease Models, AnimalDominance-SubordinationEndocannabinoidsExtinction, PsychologicalFearInflammationMaleMice, Inbred C57BLMonocytesMorpholines(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneAnti-Inflammatory Agents, Non-SteroidalBenzoxazinesCannabinoid Receptor AgonistsEndocannabinoidsMorpholinesNaphthalenesPsychotropic Drugs

Identifiers

PMID29786066
PMCPMC6046035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.